A novel human Fab antibody for Trop2 inhibits breast cancer growth in vitro and in vivo

Author:

Lin Hong1234,Zhang Huiling5,Wang Jun6,Lu Meiping7,Zheng Feng1,Wang Changjun1,Tang Xiaojun2,Xu Ning2,Chen Renjie8,Zhang Dawei8,Zhao Ping9,Zhu Jin12,Mao Yuan3,Feng Zhenqing2

Affiliation:

1. Huadong Medical Institute of BiotechniquesNanjing China

2. The Key Laboratory of Cancer BiomarkersPrevention & Treatment Cancer Center and The Key Laboratory of Antibody Technique of Ministry of HealthNanjing Medical UniversityNanjing China

3. Department of Otolaryngology‐Head and Neck SurgeryJiangsu Provincial HospitalNanjing China

4. Jiangsu Provincial Blood CenterNanjing China

5. Department of Gynecology and ObstetricsNanjing Maternal and Children Care Hospital Affiliated to Nanjing Medical UniversityNanjing China

6. Department of Hematology and OncologyJiangsu Provincial HospitalNanjing China

7. Department of Otolaryngology‐Head and Neck SurgeryThe First Affiliated Hospital of Nanjing Medical UniversityNanjing China

8. Department of Otolaryngology‐Head and Neck SurgeryThe Second Affiliated Hospital of Nanjing Medical UniversityNanjing China

9. Van Andel Research InstituteGrand Rapids MI, USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3